Global Blood Therapeutics Operating Expenses 2011-2026 | GBT

Annual Operating Expenses Global Blood Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	366 M	292 M	183 M	119 M	83.1 M	46.4 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
366 M	46.4 M	182 M

Quarterly Operating Expenses Global Blood Therapeutics

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	68.7 M	60.8 M	52.5 M	-	45.5 M	42.5 M	42.7 M	-	29.2 M	24.4 M	23.7 M	-	21.1 M	17.8 M	16.7 M	-	14.8 M	8.6 M	7.42 M	-	5.2 M	5.13 M	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
68.7 M	5.13 M	28.6 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Incyte Corporation INCY	1.62 B	$ 90.47	0.02 %	$ 17.7 B	USA
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Aileron Therapeutics ALRN	65.1 M	-	10.36 %	$ 9.8 M	USA
Ascendis Pharma A/S ASND	338 M	$ 215.49	-1.18 %	$ 5 B	Danmark
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Amphastar Pharmaceuticals AMPH	216 M	$ 19.43	1.04 %	$ 908 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
CytomX Therapeutics CTMX	98.6 M	$ 4.19	-5.95 %	$ 578 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
CollPlant Biotechnologies Ltd. CLGN	8.73 M	$ 0.72	18.96 %	$ 8.25 M	Israel
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Exelixis EXEL	598 M	$ 41.39	-0.05 %	$ 11.2 B	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.35	-3.57 %	$ 344 M	Britain
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
ChemoCentryx CCXI	120 M	-	-	$ 3.74 B	USA
Aytu BioScience AYTU	53.7 M	$ 2.59	-1.52 %	$ 16.3 M	USA
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Bellerophon Therapeutics BLPH	22.4 M	-	-74.18 %	$ 955 K	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	52.2 M	$ 4.29	-3.05 %	$ 822 M	Canada
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Ionis Pharmaceuticals IONS	752 M	$ 69.54	-1.77 %	$ 11.1 B	USA
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Calithera Biosciences CALA	125 M	-	-10.95 %	$ 876 K	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Cara Therapeutics CARA	142 M	-	-3.03 %	$ 260 M	USA
Harmony Biosciences Holdings HRMY	462 M	$ 27.01	-2.14 %	$ 1.55 B	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA